Last reviewed · How we verify
NCT04368169
The Effects of an Aromatic Botanical Extract on Respiratory Health.
NA trial testing Teramune Botanical Extract in Respiratory Health in 71 participants. Completed in 30 November 2020.
30 September 2020
Quick facts
| Lead sponsor | Nutraceuticals Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 71 |
| Start date | 27 April 2020 |
| Primary completion | 30 September 2020 |
| Estimated completion | 30 November 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Teramune Botanical Extract
- Placebo
Conditions studied
- Respiratory Health — all drugs for Respiratory Health →
Sponsor
Nutraceuticals Research Institute
Who can join
Adults 18 to 60, female only, with Respiratory Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized, double blind, placebo controlled, intervention study evaluating the effect of an aromatic botanical extract on overall respiratory health among otherwise healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Throat Spray With Blended Essential Oils Promotes Healthy Lung Function Among Women: A Randomized, Double Blinded, Placebo Controlled Clinical Trial.
Hawkins J, Hires C, Dunne E, Keenan L. · · 2022 · cited 2× · PMID 35849434 · DOI 10.1177/2515690x221113335
Verify or expand the search:
- PubMed search for NCT04368169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Health
Currently open trials in the same condition.
- NCT04170881 — CRESPI - Respiratory Health of Children in Daycare · active not recruiting
Other Nutraceuticals Research Institute trials
Trials by the same sponsor.
- NCT07210229 — The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, P · NA · not yet recruiting
- NCT06919328 — Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+ · NA · recruiting
- NCT06793891 — Effects of Ashwagandha Extract on Stress Levels · NA · recruiting
- NCT06894108 — The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality · NA · completed
- NCT06382688 — IV Administration of ChromaDex's Niagen® as Compared to NAD+ · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04368169 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 8 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutraceuticals Research Institute
- Last refreshed: 26 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04368169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing